A$16.2 million - not enough to undertake a clinical trial in the USA and keep the lights on by the looks ... lucky the options could provide more $ I guess if the share price ever gets to the exercise price ?
So as at 31 March the company had $13.5 million and as at 30 June they only have $16.2 million with a $7 million injection during the quarter from the CR ... seems the June quarter was expensive - perhaps Ross got an expensive golden handshake ?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 16.0¢ | $1.021K | 6.379K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 77738 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 3400 | 1 |
View Market Depth
| Last trade - 09.59am 24/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |